September 17th 2025, 9:00pm
I reflect on how my family and friends showed love in different ways during the early days of my chronic cancer diagnosis.
September 17th 2025, 8:00pm
Researchers have created a novel immunotherapy for metastatic kidney cancer that could provide a new treatment option for patients with limited options.
September 17th 2025, 7:00pm
For patients with advanced GIST, complete surgical removal of metastases and full response to Gleevec are associated with roughly double the survival time.
September 17th 2025, 5:00pm
Having been through two bouts of breast cancer, I am happy to be on this planet with my family, friends and neighbors.
September 17th 2025, 4:00pm
Bob Lane, a prostate cancer survivor, discusses the stigma men often feel when talking about prostate cancer.
September 17th 2025, 3:10pm
The FDA granted orphan drug designation to ligufalimab for AML, reflecting its potential as an immune-based therapy that may offer new options for patients.
September 17th 2025, 1:00pm
Dr. Prithviraj Bose discusses how patients with myelofibrosis can better understand their options and access the most up-to-date advancements in care.
September 16th 2025, 9:00pm
The first day of fall comes on September 22, and every year it feels like a reminder to pause.
September 16th 2025, 8:00pm
Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.
September 16th 2025, 7:00pm
Dr. Prithviraj Bose explains how doctors tailor myelofibrosis treatments and how patients can work with their care teams to navigate options.
The Defining Moments of Support After Hearing ‘You Have Cancer’
Off-the-Shelf Immunotherapy May Offer Benefits in Kidney Cancer
Gleevec Associated With Long-Term Effectiveness in Treating GIST
The Days of a Breast Cancer Survivor